What is the name of the hyperplasia that occurs during wound healing in patients with psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pseudoepitheliomatous Hyperplasia

The hyperplasia that occurs during wound healing in psoriasis patients is called pseudoepitheliomatous hyperplasia (PEH).

What is Pseudoepitheliomatous Hyperplasia?

Pseudoepitheliomatous hyperplasia is characterized by reactive epithelial downward proliferation into the dermis, manifesting as irregular cords of epithelial cells extending from the epidermis into deeper tissue layers 1. This represents an exaggerated wound healing response rather than a malignant process, despite its sometimes alarming histological appearance.

Key Clinical Features

The condition develops specifically in the context of:

  • Improper wound management following cutaneous injury in psoriatic skin
  • Bacterial colonization - cultures consistently grow bacteria from PEH lesions, often resistant to multiple antibiotics except vancomycin 1
  • Epidermal hyperplasia with downward extension that can mimic squamous cell carcinoma histologically

Pathophysiological Mechanism

The formation of PEH involves dysregulated stem cell signaling:

  • Stem cell factor (SCF) shows stronger expression in sweat gland epithelial cells and interstitial cells within PEH tissue compared to normal adjacent skin
  • c-Kit receptor demonstrates increased expression by interstitial cells in affected areas
  • This SCF/c-Kit pathway activation drives the abnormal epidermal proliferation characteristic of PEH 1

Clinical Management

Definitive treatment requires radical surgical excision combined with daily vancomycin dressings to address both the hyperplastic tissue and underlying bacterial infection 1. This dual approach targets both the structural abnormality and the infectious trigger that perpetuates the condition.

Important Distinction

This phenomenon differs from the baseline epidermal hyperproliferation seen in psoriatic plaques themselves, which involves keratinocyte hyperproliferation driven by inflammatory cytokines and immune dysregulation 2, 3. PEH represents a specific complication of wound healing rather than the primary disease process.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.